These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22439687)

  • 1. Green amorphous nanoplex as a new supersaturating drug delivery system.
    Cheow WS; Hadinoto K
    Langmuir; 2012 Apr; 28(15):6265-75. PubMed ID: 22439687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility.
    Cheow WS; Hadinoto K
    J Colloid Interface Sci; 2012 Feb; 367(1):518-26. PubMed ID: 22051687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate.
    Cheow WS; Hadinoto K
    Colloids Surf B Biointerfaces; 2012 Apr; 92():55-63. PubMed ID: 22154010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
    Nguyen MH; Yu H; Kiew TY; Hadinoto K
    Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphous nanoparticle complex of perphenazine and dextran sulfate as a new solubility enhancement strategy of antipsychotic perphenazine.
    Dong B; Hadinoto K
    Drug Dev Ind Pharm; 2017 Jun; 43(6):996-1002. PubMed ID: 28121189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the stability of amorphous drug-polyelectrolyte nanoparticle complex using a secondary small-molecule drug as the stabilizer: A case study of ibuprofen-stabilized curcumin-chitosan nanoplex.
    Lim LM; Hadinoto K
    Int J Pharm; 2020 Feb; 575():119007. PubMed ID: 31893545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxymethyl cellulose is a superior polyanion to dextran sulfate in stabilizing and enhancing the solubility of amorphous drug-polyelectrolyte nanoparticle complex.
    Dong B; Hadinoto K
    Int J Biol Macromol; 2019 Oct; 139():500-508. PubMed ID: 31386874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albumin.
    Yu H; Nguyen MH; Cheow WS; Hadinoto K
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():25-33. PubMed ID: 28415461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof-of-concept preparation and characterization of dual-drug amorphous nanoparticle complex as fixed-dose combination of poorly soluble drugs.
    Yu H; Ming Lim L; Dong B; Hadinoto K
    Drug Dev Ind Pharm; 2019 Jan; 45(1):105-116. PubMed ID: 30196726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
    Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
    Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP.
    Dong B; Lim LM; Hadinoto K
    Eur J Pharm Sci; 2019 Oct; 138():105035. PubMed ID: 31386892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug-Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug.
    Lim LM; Park JW; Hadinoto K
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles.
    Cheow WS; Kiew TY; Yang Y; Hadinoto K
    Mol Pharm; 2014 May; 11(5):1611-20. PubMed ID: 24669821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Millifluidic synthesis of amorphous drug-polysaccharide nanoparticle complex with tunable size intended for supersaturating drug delivery applications.
    Tran TT; Nguyen MH; Tan YZ; Chew JW; Khan SA; Hadinoto K
    Eur J Pharm Biopharm; 2017 Mar; 112():196-203. PubMed ID: 27903456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailor-made release triggering from hot-melt extruded complexes of basic polyelectrolyte and poorly water-soluble drugs.
    Kindermann C; Matthée K; Strohmeyer J; Sievert F; Breitkreutz J
    Eur J Pharm Biopharm; 2011 Oct; 79(2):372-81. PubMed ID: 21596136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan.
    Nguyen MH; Yu H; Dong B; Hadinoto K
    Eur J Pharm Sci; 2016 Jun; 89():163-71. PubMed ID: 27140843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple strategy to enhance the in vivo wound-healing activity of curcumin in the form of self-assembled nanoparticle complex of curcumin and oligochitosan.
    Nguyen MH; Lee SE; Tran TT; Bui CB; Nguyen TH; Vu NB; Tran TT; Nguyen TH; Nguyen TT; Hadinoto K
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():54-64. PubMed ID: 30813056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling the burst release of amorphous drug-polysaccharide nanoparticle complex via crosslinking of the polysaccharide chains.
    Nguyen MH; Tran TT; Hadinoto K
    Eur J Pharm Biopharm; 2016 Jul; 104():156-63. PubMed ID: 27179586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations.
    Gosangari S; Dyakonov T
    Pharm Dev Technol; 2013; 18(2):475-80. PubMed ID: 22881446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
    Cheow WS; Kiew TY; Hadinoto K
    Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.